Provided by Tiger Trade Technology Pte. Ltd.

Erytech Pharma S.A.

0.7800
0.0000
Volume:- -
Turnover:2.73K
Market Cap:26.61M
PE:-72.99
High:0.7800
Open:0.7800
Low:0.7800
Close:0.7800
52wk High:1.47
52wk Low:0.3000
Shares:34.12M
Float Shares:30.78M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0107
EPS(LYR):-0.0079
ROE:-0.98%
ROA:-30.14%
PB:0.98
PE(LYR):-99.29

Loading ...

Company Profile

Company Name:
Erytech Pharma S.A.
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
ERYTECH Pharma S.A., a biopharmaceutical company, focus on development of red blood cell-based therapeutics for cancer and orphan diseases in France and the United States. It develops eryaspase, which is in Phase 3 clinical development for the treatment of second-line pancreatic cancer, and in Phase 2 stage for the treatment of triple-negative breast cancer and second-line acute lymphoblastic leukemia patients. The company also engages in developing erymethionase, a preclinical product candidate that consists of methionine-?-lyase in red blood cells to target the amino acid metabolism of cancer cells and induce tumor starvation. ERYTECH Pharma S.A. was incorporated in 2004 and is headquartered in Lyon, France.